Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing’s Disease
Condition(s):Cushings DiseaseLast Updated:September 18, 2020Terminated
Hide Studies Not Open or Pending
Condition(s):Cushings DiseaseLast Updated:September 18, 2020Terminated
Condition(s):MigraineLast Updated:February 26, 2024Completed
Condition(s):Lactation SuppressedLast Updated:February 22, 2024Enrolling by invitation
Condition(s):Lactation SuppressedLast Updated:February 13, 2024Completed
Condition(s):Polycystic Ovarian Syndrome; Ovarian Hyperstimulation SyndromeLast Updated:April 4, 2012Completed
Condition(s):Cushing’s Disease; Corticotroph AdenomaLast Updated:April 29, 2009Completed
Condition(s):Pituitary Adenoma; Nonfunctioning Pituitary AdenomaLast Updated:September 7, 2017Completed
Condition(s):InfertilityLast Updated:February 2, 2016Completed
Condition(s):AcromegalyLast Updated:November 17, 2009Completed
Condition(s):Complications Associated With Artificial Fertilization; Disorder of Endocrine OvaryLast Updated:February 10, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.